Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer.

Lambrechts, Sandrina

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. [electronic resource] - BMC pharmacology & toxicology Feb 2015 - 2 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2050-6511

10.1186/s40360-015-0001-5 doi


Adult
Aged
Aged, 80 and over
Anemia--chemically induced
Carboplatin--administration & dosage
Carrier Proteins--genetics
Colony-Stimulating Factors--adverse effects
DNA Repair--genetics
Female
Genotype
Hematinics--adverse effects
Humans
Inactivation, Metabolic--genetics
Middle Aged
Multidrug Resistance-Associated Protein 2
Neurotoxicity Syndromes--genetics
Ovarian Neoplasms--drug therapy
Paclitaxel--administration & dosage
Polymorphism, Single Nucleotide--genetics
Thrombocytopenia--chemically induced
Young Adult